Adam J. Townsend, Chief Commercial Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 10,000 shares at $50.38 ($327K) on 2022-12-05, disclosed to the SEC on 2022-12-07.
Open-market sale of $327k APLS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.09 | 5,000 | $75K | 23.0% |
| 2 | $50.38 | 5,000 | $252K | 77.0% |
| Total | $32.73 avg | 10,000 | $327K | 100% |
| Filing → |
| APLS | SELL | 2025-01-21 | $132K | — | Filing → |
| APLS | SELL | 2025-01-14 | $154K | — | Filing → |
| APLS | SELL | 2024-02-13 | $156K | — | Filing → |